Gallium-68 Market Size, Share, and Growth 2021-2022
Gallium-68 Market: Size and Share
-
CAGR (2022 - 2030)4.0% -
Market Size 2022
US$ 782.36 Million -
Market Size 2030
US$ 1,070.34 Million
Market Dynamics
- Rising demand for positron emission tomography (PET) scans
- Advancements in radiopharmaceuticals
- Growing applications in cancer diagnostics
- Technological advancements in Gallium-68 production
- Rise of personalized and targeted cancer treatment
- Increasing focus on non-invasive diagnostic tools
- Rising applications of Gallium-68 in personalized medicine
- Growing market for diagnostic imaging technologies
- Expansion of PET imaging in clinical settings
Market Segmentation
Application - Oncology
- Neurology
- Cardiology
End User - Hospitals
- Diagnostic and Imaging Centers
Gallium-68 Market Players Density: Understanding Its Impact on Business Dynamics
The Gallium-68 Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Gallium-68 Market are:
- Novartis AG
- Telix Pharmaceuticals (US) Inc
- IRE-ELiT SA
- ITM Medical Isotopes GmbH
- Eckert & Ziegler Radiopharma GmbH
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Gallium-68 Market top key players overview
Get Free Sample For